Sarcoidosis (SA) is accompanied by malignancy more than can be explained by chance. Cancer can occur in patients with an established diagnosis of SA and SA can subsequently develop in a cancer patient. Malignancy can also be associated with the occurrence of sarcoid reactions (SR), which are typically restricted to the regional lymph nodes. Problems may also arise in distinguishing between tumour-related SRs and true systemic SA. Here we present a case with both SA and pancreatic cancer, and we discuss the result of distinguishing between SA and SRs in a patient with concurrent cancer.
Brincker H, Pedersen NT (1991) Immunohistologic separation of B-cell-positive granulomas from B-cell-negative granulomas in paraffin-embedded tissue with special reference to tumor-related sarcoid reactions. APMIS 99:282–290PubMedCrossRefGoogle Scholar
Boros DL (1983) Experimental granulomatous disease. In: Fanberg BL (ed.) Sarcoidosis and other granulomatous diseases of the lung. Marcel Dekker, New York, pp 403–449Google Scholar
Brincker H (1992) Interpretation of granulomatous lesion in malignancy. Acta Oncol 6:85–89CrossRefGoogle Scholar
Trump KL, Ettinger DS, Feldman JM et al (1981) Sarcoidosis and sarcoid-like lesions: their occurrence after cytotoxic and radiation therapy of testis cancer. Arch Intern Med 141:37–38PubMedCrossRefGoogle Scholar